Clinical trial
UBT251 Injection Phase II Clinical Study (CKD)
NCT07134335
Study timeline
Study start (actual)2025-09-01Date precision: day
Registry last updated2025-11-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesity &Amp; Overweightunresolved
Chronic Kidney Diseaseunresolved
Interventions
Sponsors & collaborators
The United Bio-Technology (Hengqin) Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07134335 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.